ES2061727T3 - Sustancias fisiologicamente activas, un procedimiento para su preparacion y composiciones farmaceuticas que las contienen. - Google Patents

Sustancias fisiologicamente activas, un procedimiento para su preparacion y composiciones farmaceuticas que las contienen.

Info

Publication number
ES2061727T3
ES2061727T3 ES88810760T ES88810760T ES2061727T3 ES 2061727 T3 ES2061727 T3 ES 2061727T3 ES 88810760 T ES88810760 T ES 88810760T ES 88810760 T ES88810760 T ES 88810760T ES 2061727 T3 ES2061727 T3 ES 2061727T3
Authority
ES
Spain
Prior art keywords
physiologically active
active substances
procedure
contain
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88810760T
Other languages
English (en)
Inventor
Jin-Emon C O Inst Of B Konishi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Zoki Pharmaceutical Co Ltd
Original Assignee
Nippon Zoki Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Zoki Pharmaceutical Co Ltd filed Critical Nippon Zoki Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2061727T3 publication Critical patent/ES2061727T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24132—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A UNA SUSTANCIA ACTIVA FISIOLOGICAMENTE EXTRAIDA DE TEJIDOS INYECTADOS INOCULADOS CON UN POXVIRUS. LAS SUSTANCIAS DE LA PRESENTE INVENCION TIENEN ACCIONES EXCELENTES PARA MEJORAR LA CIRCUACION SANGUINEA Y RECUPERAR LAS FUNCIONES DE TEJIDOS ENFERMOS, ADEMAS SON UTILES COMO DROGAS PARA VARIAS ENFERMEDADES CAUSADAS POR LAS ALTERACIONES DE LA CIRCULACION SANGUINEA.
ES88810760T 1987-11-06 1988-11-07 Sustancias fisiologicamente activas, un procedimiento para su preparacion y composiciones farmaceuticas que las contienen. Expired - Lifetime ES2061727T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP28176487 1987-11-06

Publications (1)

Publication Number Publication Date
ES2061727T3 true ES2061727T3 (es) 1994-12-16

Family

ID=17643645

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88810760T Expired - Lifetime ES2061727T3 (es) 1987-11-06 1988-11-07 Sustancias fisiologicamente activas, un procedimiento para su preparacion y composiciones farmaceuticas que las contienen.

Country Status (5)

Country Link
US (1) US4985254A (es)
EP (1) EP0315591B1 (es)
AT (1) ATE87484T1 (es)
DE (1) DE3879873T2 (es)
ES (1) ES2061727T3 (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0341209B1 (en) * 1988-04-30 1993-09-15 Nippon Zoki Pharmaceutical Co. Ltd. Physiologically active substances, a process for preparation and pharmaceutical compositions thereof
JP2588109B2 (ja) * 1993-03-19 1997-03-05 日本臓器製薬株式会社 鎮痛剤
JP3213832B2 (ja) * 1993-08-06 2001-10-02 日本臓器製薬株式会社 被検物質の活性測定法
JP3213831B2 (ja) * 1993-08-06 2001-10-02 日本臓器製薬株式会社 被検物質の活性測定方法
JP2594222B2 (ja) * 1993-09-28 1997-03-26 日本臓器製薬株式会社 新規生理活性物質−ｋｆ
AU721804B2 (en) * 1997-01-08 2000-07-13 Nippon Zoki Pharmaceutical Co., Ltd. Nitrogen monoxide production suppressor
JP4033936B2 (ja) * 1997-01-08 2008-01-16 日本臓器製薬株式会社 一酸化窒素産生抑制剤
JPH1180005A (ja) * 1997-09-12 1999-03-23 Nippon Zoki Pharmaceut Co Ltd 骨粗鬆症治療剤
KR19990044835A (ko) 1997-11-28 1999-06-25 고니시 진우에몬 생약추출물
CA2270050A1 (en) * 1998-04-27 1999-10-27 Jin-Emon Konishi A therapeutic agent for ischemic diseases
AU763224B2 (en) 1999-04-15 2003-07-17 Nippon Zoki Pharmaceutical Co., Ltd. Novel bioactivating substance
US6726932B2 (en) 2000-02-18 2004-04-27 Nippon Zoki Pharmaceutical Co., Ltd. Fatty acid-containing composition
US6913900B2 (en) * 2001-08-29 2005-07-05 Nippon Zoki Pharmaceutical Co., Ltd. Plasma prekallikrein activation and kallikrein production assay
CN1207005C (zh) * 2002-10-31 2005-06-22 威世药业（如皋）有限公司 含生物活性物质的兔皮和其用途
KR101307999B1 (ko) * 2004-12-01 2013-09-12 니폰 조키 세야쿠 가부시키가이샤 건조물 및 그 제조방법
US20060134646A1 (en) * 2004-12-17 2006-06-22 Ansari Aftab A Method for treatment of HIV infection
WO2007090081A2 (en) * 2006-01-27 2007-08-09 The Board Of Governors For Higher Education State Of Rhode Island And Providence Plantations Analysis of mycophenolic acid in saliva using liquid chromatography tandem mass spectrometry
CN101732348B (zh) * 2008-11-11 2015-01-14 威世药业（如皋）有限公司 牛痘疫苗致炎兔皮提取物在制备急性脑血管疾病治疗药物中的用途
TWI483729B (zh) 2010-03-11 2015-05-11 Nippon Zoki Pharmaceutical Co 慢性前列腺炎、間質性膀胱炎及／或排尿障礙之改善或治療劑
EP2627343B1 (en) 2010-10-14 2018-01-10 Nippon Zoki Pharmaceutical Co., Ltd. Agents for use for promoting the synthesis of collagen and proteoglycan in intervertebral disc cells
CA2909234C (en) 2013-04-30 2023-03-14 Nippon Zoki Pharmaceutical Co., Ltd. Extracts and preparation thereof from inflamed skins of rabbits inoculated with vaccinia virus
WO2016022917A2 (en) * 2014-08-08 2016-02-11 The Regents Of The University Of California A method for protecting liver and a liver protecting agent

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5835117A (ja) * 1981-08-25 1983-03-01 Nippon Zoki Pharmaceut Co Ltd 新規生理活性物質ｎｓｈ
JP2651674B2 (ja) * 1987-07-23 1997-09-10 日本臓器製薬 株式会社 新規生理活性物質及びその製造方法
FR2649273B1 (fr) * 1989-06-30 1991-09-13 Portenseigne Radiotechnique Dispositif d'egalisation autoadaptative pour des echantillons numeriques codes en duobinaire
JP3469377B2 (ja) * 1995-10-25 2003-11-25 信越化学工業株式会社 塩化ビニル系重合体の製造方法

Also Published As

Publication number Publication date
EP0315591B1 (en) 1993-03-31
EP0315591A3 (en) 1990-05-16
EP0315591A2 (en) 1989-05-10
DE3879873T2 (de) 1993-08-05
US4985254A (en) 1991-01-15
DE3879873D1 (de) 1993-05-06
ATE87484T1 (de) 1993-04-15

Similar Documents

Publication Publication Date Title
ES2061727T3 (es) Sustancias fisiologicamente activas, un procedimiento para su preparacion y composiciones farmaceuticas que las contienen.
ES2045182T3 (es) Substancias fisiologicamente activas, un proceso para la preparacion de las mismas y composiciones farmaceuticas que las contienen.
IT1241996B (it) Composizione farmaceutica per il trattamento di disturbi respiratori e metodo per la sua applicazione.
ATE204178T1 (de) Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin
BR9714363A (pt) Derivados de pirazol substituìdos para o tratamento de doenças circulatórias cardìacas
PT88985A (pt) Processo para a preparacao de composicoes farmaceuticas nasais e ou oftalmicas contendo azelastina
RU94002475A (ru) Фармацевтическая композиция и ее применение для лечения вирусных инфекций
ATE157257T1 (de) Verstärkung der unterdrückungsregulation von autoimmunkrankheiten durch orale oder enterale verabreichung von autoantigenen
ES532515A0 (es) Un procedimiento para la preparacion de formulaciones medicamentosas de nifedipina en dos fases, para el tratamiento de enfermedades circulatorias y coronarias.
MX9203543A (es) Medicamento.
HUP0203437A2 (en) Use of resorcinol derivatives for producing pharmaceutical compositions for treatment of immune diseases
FR2512670B1 (fr) Capsules contenant le principe actif d'un allergene et procede pour leur preparation
ES2058592T3 (es) El uso de sustancias activas fisiologicamente para la fabricacion de medicamentos para enfermedades cerebrales y neuronales.
ATE122885T1 (de) Mittel zur behandlung von herzerkrankungen.
DE69002718D1 (de) Medikamente.
DE68929388D1 (de) Aus Harn isolierte antikoagulierende Verbindung
IT8322855A0 (it) Composizione farmaceutica per la cura delle arteriopatie periferiche.
ATE20309T1 (de) Pharmazeutische zubereitung.
MX163574B (es) Procedimiento para preparar una composicion farmaceutica para inhalacion conteniendo un gangliosido
ES2059816T3 (es) Sustancias activas fisiologicamente, un procedimiento para la preparacion y composiciones farmaceuticas de las mismas.
ATE174798T1 (de) Die herstellung von zusammensetzungen zur behandlung von krankheiten der zellproliferation
SE8704952L (sv) Farmaceutisk komposition
HUP0202525A2 (hu) Mofetil mikofenolát és PEG-IFN-alfa együttes alkalmazása, valamint az azokat tartalmazó gyógyszerkészítmények és kit
DE69621786D1 (de) Aminotetralinderivat zur behandlung von herzkreislauferkrankung
KR890012942A (ko) 5-치환된 오르니틴 유도체

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 315591

Country of ref document: ES